GLP-1 guides

A dated list of new GLP-1 pills, pens, uses and label changes from late 2024 to 2026, each tied to an FDA or DailyMed record, with no dosing guidance.

What the Ozempic pill label says: Ozempic tablets vs Rybelsus, who it is for, how it is taken, side effects, interactions and storage.

What the Foundayo label says about who it is for, how the daily tablet is taken, trial side effects, drug interactions, birth control pills and storage.

A dated list of GLP-1 drugs with current US labels: brand and generic names, shots and pills, weekly or daily, and the uses each label lists.

What the Ozempic label and IFU say about the pen and its needles: the flow check, why not to count clicks, injection sites, storage and disposal.

How the Wegovy single-dose pen, FlexTouch pen and prefilled syringe differ on the label: IFU steps, injection sites, storage and disposal.

What the Wegovy pill label says about who it is for, how the tablet is taken and why, the side effects reported in its trial, interactions, and storage.

How the Zepbound single-dose pen and the multi-dose KwikPen differ on the label: devices, what the Instructions for Use cover, storage, and disposal.

How often constipation and diarrhea occurred in Wegovy, Zepbound and Foundayo trials, what the labels say about dehydration and blockage, and when to call.

Fatigue is listed on GLP-1 labels. See the percentages in Wegovy, Zepbound and Foundayo trials, how low blood sugar can look similar, and when to call a doctor.

Hair loss is listed on GLP-1 labels. See the Wegovy and Zepbound trial percentages, what a weight-loss hair study found, and when to see a doctor.

How often nausea and vomiting occurred in Wegovy, Zepbound, Foundayo, Ozempic and Mounjaro trials, what the labels say about timing and dehydration.

How to dispose of used GLP-1 pens and needles safely, based on FDA sharps guidance and the Wegovy, Zepbound and Ozempic labels: containers, rules and travel.

How the Ozempic, Wegovy and Zepbound labels say to store pens, how long they can stay unrefrigerated, and what TSA says about flying with injectable medicine.

How GLP-1 pills and injections differ on the labels: how each is taken, what they are indicated for, and the side effects reported for Wegovy and Foundayo.

The Ozempic, Wegovy, Mounjaro, Zepbound and Foundayo labels give half-lives from about 1 to 2 days up to 1 week. See what that means and why labels mention it.

What Medicare covers for GLP-1 drugs as of October 30, 2026: the CMS GLP-1 Bridge for weight management, Part D for diabetes and sleep apnea, and the $50 copay.

Ozempic and Wegovy both contain semaglutide, and Mounjaro and Zepbound both contain tirzepatide. See how each brand's FDA label differs and why that matters.

Tirzepatide and semaglutide compared using their FDA labels and one head-to-head trial: how they work, what each is approved for, half-lives and warnings.

A plain-language explanation of GLP-1 medicines such as Wegovy, Ozempic and Zepbound: what GLP-1 is, how the labels describe them, and what they treat.

Common GLP-1 side effects from the Wegovy and Zepbound labels, with the percentages reported in trials, the serious warnings, and when to call your doctor.

What the Ozempic, Wegovy and Zepbound labels say about GLP-1 injection sites: which body areas are listed, how rotation works, and when to call your doctor.